Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma

Cancer Treatment Reviews
Michael B Atkins, Nizar M Tannir

Abstract

There has been significant progress in the treatment of patients with advanced clear cell renal cell carcinoma (ccRCC), with improved knowledge of disease biology and the introduction of targeted agents and immunotherapies. In this review, we discuss current and emerging first-line treatment options, including recent approvals of the tyrosine kinase inhibitor (TKI) cabozantinib and the immunotherapy combination of nivolumab (anti-programmed cell death 1 [PD-1])/ipilimumab (anti-cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4]), and initial outcomes with the combination of atezolizumab (anti-PD-ligand 1 [PD-L1])/bevacizumab (anti-vascular endothelial growth factor [VEGF]). Key clinical data are reviewed, as these novel first-line treatments offer significant improvement, particularly for patients classified as intermediate/poor risk for whom previously available therapies have demonstrated limited efficacy. Treatment recommendations based on clinical evidence and expert opinion are discussed. We also review ongoing studies investigating combinations of checkpoint inhibitors with TKIs, including cabozantinib and axitinib, and with other novel immunomodulatory agents, and the potential role of single-agent immunotherapy for se...Continue Reading

Citations

Jan 16, 2019·Current Urology Reports·Caroline E Nunes-XavierJosé I López
Feb 7, 2019·Cardiovascular Research·Jorie VersmissenA H Jan Danser
Apr 2, 2019·Current Topics in Medicinal Chemistry·Wenjie Wang, Yuk-Ching Tse-Dinh
Nov 14, 2019·International Journal of Molecular Sciences·Prasanta DeyHyung Sik Kim
Nov 20, 2019·International Journal of Molecular Sciences·Fuyan HuXiaoping Liu
Sep 9, 2019·Histopathology·Marie-Lisa EichGeorge J Netto
Jun 26, 2020·Technology in Cancer Research & Treatment·Haoyuan CaoWei Wang
May 4, 2020·World Journal of Urology·Sanaz GhafouriAlexandra Drakaki
Jan 14, 2021·Current Treatment Options in Oncology·Bryce R ChristensenPedro C Barata
Jan 8, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Daniel J PrzybylskiJennifer K Piccolo
Feb 25, 2020·Transplantation·Raphael P H MeierThierry Berney
Jan 7, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Taruna RajagopalNageswara Rao Dunna
Jan 8, 2021·Cancer Management and Research·Rui PengHan Guan
Jan 12, 2021·Oxidative Medicine and Cellular Longevity·Xia Qi-DongShao-Gang Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.